Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.24 USD | +0.26% | -5.17% | -35.31% |
Apr. 20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
Apr. 20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.41M | Capitalization | 3.95B |
---|---|---|---|---|---|
Net income 2024 * | -250M | Net income 2025 * | -276M | EV / Sales 2024 * | - |
Net cash position 2024 * | 653M | Net cash position 2025 * | 532M | EV / Sales 2025 * | 237 x |
P/E ratio 2024 * |
-15.2
x | P/E ratio 2025 * |
-14.9
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.86% |
Latest transcript on Immunovant, Inc.
1 day | +0.70% | ||
1 week | -5.17% | ||
Current month | -15.65% | ||
1 month | -13.78% | ||
3 months | -30.68% | ||
6 months | -17.21% | ||
Current year | -35.31% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 19-05-31 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 21-10-03 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 19-12-17 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 19-12-17 |
Douglas Hughes
BRD | Director/Board Member | 62 | 19-12-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 27.28 | +0.40% | 388 673 |
24-04-26 | 27.17 | -2.09% | 1,414,961 |
24-04-25 | 27.75 | -3.65% | 1,270,174 |
24-04-24 | 28.8 | +0.66% | 731,097 |
24-04-23 | 28.61 | -0.45% | 1,063,348 |
Delayed Quote Nasdaq, April 29, 2024 at 11:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.31% | 3.95B | |
+2.29% | 42.75B | |
+47.70% | 41.61B | |
+11.64% | 41.34B | |
-12.36% | 26.59B | |
+8.66% | 25.49B | |
-22.92% | 18.12B | |
+30.86% | 12.24B | |
-1.48% | 11.76B | |
+8.46% | 11B |
- Stock Market
- Equities
- IMVT Stock